Stock comparison
Lam Research
Silicon Laboratories
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LRCX
Lam Research
Market cap
$381.86B
Sector
Technology
SLAB
Silicon Laboratories
Market cap
$7.17B
Sector
Technology
Overall winner
Lam Research LRCX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LRCX | SLAB | Winner |
|---|---|---|---|
| Warren Buffett | 78B | 18F | LRCX |
| Benjamin Graham | 88A | 53D | LRCX |
| Philip Fisher | 76B | 26F | LRCX |
| Peter Lynch | 69B | 4F | LRCX |
| Joel Greenblatt | 84C | 0F | LRCX |
| Charlie Munger | 86A | 25F | LRCX |
| Terry Smith | 88A | 27F | LRCX |
Side-by-side metrics
| Metric | LRCX | SLAB |
|---|---|---|
| Market cap | $381.86B | $7.17B |
| P/E (TTM) | 55.4x | - |
| EV/EBIT | 62.9x | - |
| ROIC (TTM) | 42.79% | -3.91% |
| Gross margin | 49.98% | 58.52% |
| Net margin | 30.94% | -6.13% |
| Revenue CAGR 5y | 5.96% | 2.15% |
| EPS CAGR 5y | 11.27% | - |
| Debt / Equity | 0.4x | - |
| Dividend yield | 0.34% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LRCX leads on
- Net margin30.94%vs -6.13%+120%
- ROIC (TTM)42.79%vs -3.91%+109%
- Dividend yield0.34%vs 0.0%+100%
- Market cap$381.86Bvs $7.17B+98%
SLAB leads on
- EV/EBIT-vs 62.9x+166%
- P/E (TTM)-vs 55.4x+139%
- Debt / Equity-vs 0.4x+100%
- Gross margin58.52%vs 49.98%+15%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.